Evidence map›Paper›PMID 42328234›Full record

ReviewFrontiers in systems biology2026

Multilayer network approaches to omics data integration in digital twins for cancer research.

Hugo Chenel, Malvina Marku, Tim James, Andrei Zinovyev, Vera Pancaldi

Abstract readReview
In one paragraph

Review in Frontiers in systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hugo ChenelUniv Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Malvina MarkuUniv Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Tim JamesEvotec, Abingdon, Oxfordshire, United Kingdom.
Andrei ZinovyevEvotec, Toulouse, France.
Vera PancaldiUniv Toulouse, INSERM, CNRS, CRCT, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

How can we effectively integrate and represent heterogeneous multi-omics data to better understand complex biological systems and support the development of personalized digital models? The growing availability of high-dimensional omics data across different molecular scales presents both opportunities and challenges in biomedical research. Traditional approaches often treat each omics layer in isolation or rely on concatenation strategies that obscure the interactions between different regulatory layers. In this review, we discuss the multilayer network-based framework as an extensive representation of different omics data types, capturing the modularity, redundancy and cross-talk between layers, and providing a more faithful interpretable view of the biological system. We explore how this approach can be used as a basis for the construction of Digital Twins, computational replicas of individual biological systems capable of simulating disease progression and treatment outcomes. In contrast to existing multi-omics integration reviews), we emphasize the role of multilayer networks as a mechanistic and interpretable scaffold for Digital Twins development. We discuss key methodological considerations, benefits and potential applications of this approach, highlighting its promise for advancing both our understanding of biological complexity and our ability to design personalized interventions.

Indexed as

cancer systems biologydigital twinsmultilayer networksmulti-omics integrationnetwork medicineprecision oncology

Identifiers

PMID42328234
PMCPMC13275443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.